NylaAHeeremaMD
Medical Genetics • Columbus, OHClinical Cytogenetics
Professor, Pathology, Ohio State University College of Medicine
Dr. Heerema is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1645 Neil Ave
167 Hamilton Hall
Columbus, OH 43210Phone+1 614-366-4111Fax+1 614-688-8326
Education & Training
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1967
Certifications & Licensure
- American Board of Medical Genetics and Genomics Clinical Cytogenetics
Clinical Trials
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- Reply to: Accurate Determinants of Outcome in ALL.Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Abdelrahman Elsayed
Journal of Clinical Oncology. 2024-12-23 - Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed-rearranged acute lymphoblastic leukemia: Children's Oncol...Erin M Guest, John A Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J Carroll
Haematologica. 2024-12-01 - Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.Susan R Rheingold, Deepa Bhojwani, Lingyun Ji, Xinxin Xu, Meenakshi Devidas
Leukemia. 2024-11-01
Journal Articles
- Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic LeukemiaNyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature
- Evaluation of 230 Patients with relapsed/refractory Deletion 17p Chronic Lymphocytic Leukaemia Treated with Ibrutinib from 3 Clinical TrialsSteven Coutre, Richard R Furman, William G Wierda, Nyla A Heerema, Alvina D Chu, Jeffrey Jones, John C Byrd, British Journal of Haematology
- Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology GroupMichael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
Press Mentions
Athena Cherry, Stanford Professor of Pathology and Pediatrics, Dies at 60February 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
